0
Encephalopathy Collection
The most recent journal, In the Clinic, and Summaries for Patients articles
Articles |  7 September 2010
Variations in the Promoter Region of the Glutaminase Gene and the Development of Hepatic Encephalopathy in Patients With Cirrhosis: A Cohort Study
Manuel Romero-Gómez, MD, PhD; María Jover, PhD; José A. Del Campo, PhD; et al.
Ann Intern Med. 2010;153(5):281-288. doi:10.7326/0003-4819-153-5-201009070-00002
Editorials |  7 September 2010
Hepatic Encephalopathy in Our Genes?
Jan Albrecht, PhD
Ann Intern Med. 2010;153(5):335-336. doi:10.7326/0003-4819-153-5-201009070-00008
Reviews |  20 March 2007
Narrative Review: Fabry Disease
Joe T.R. Clarke, MD, PhD
Ann Intern Med. 2007;146(6):425-433. doi:10.7326/0003-4819-146-6-200703200-00007
ACP Journal Club |  15 October 2013
Adding rifaximin to lactulose increased reversal and decreased mortality in hepatic encephalopathy
Kris V. Kowdley, MD, FACP; Blaire E. Burman, MD
Ann Intern Med. 2013;159(8):JC8. doi:10.7326/0003-4819-159-8-201310150-02008
ACP Journal Club |  17 August 2010
Rifaximin maintained remission from hepatic encephalopathy longer than placebo in patients with cirrhosis
Brian T. Story, MD; Kris V. Kowdley, MD, FACP
Ann Intern Med. 2010;153(4):JC2-8. doi:10.7326/0003-4819-153-4-201008170-02008
ACP Journal Club |  18 November 2008
Review: Rifaximin is equally or more effective than other antibiotics and lactulose for hepatic encephalopathy
Joe Alcorn, MD
Ann Intern Med. 2008;149(10):JC5-11. doi:10.7326/0003-4819-149-10-200811180-02011
Advertisement

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)